Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 ShiseidoTakeda PharmaceuticalAlexion PharmaceuticalsGenmab A/SUCB
Price Information
Current Price$63.21$17.79$112.30$33.44$117.20
52 Week RangeBuyN/ABuyBuyBuy
Beat the Market™ Rank
Overall Score1.
Analysis Score0.
Community Score2.
Dividend Score1.
Ownership Score0.
Earnings & Valuation Score1.
Analyst Ratings
Consensus RecommendationBuyN/ABuyBuyBuy
Consensus Price TargetN/AN/A$143.95$33.40N/A
% Upside from Price TargetN/AN/A28.19% upside-0.12% downsideN/A
Trade Information
Market Cap$25.25 billion$28.01 billion$24.80 billion$21.83 billion$22.80 billion
Average Volume19,3555,902,4732,095,9011,133,332733
Sales & Book Value
Annual Revenue$10.38 billion$15.99 billion$4.99 billion$804.57 million$5.50 billion
Price / Sales2.431.744.9727.134.14
Cashflow$3.07 per share$2.37 per share$11.69 per share$0.53 per share$5.61 per share
Price / Cash20.617.529.6162.9620.89
Book Value$11.93 per share$11.62 per share$50.91 per share$3.24 per share$40.36 per share
Price / Book5.301.532.2110.322.90
Net Income$676.77 million$1.68 billion$2.40 billion$324.68 million$887.04 million
Trailing P/E Ratio65.8412.1110.5717.9820.14
Forward P/E Ratio41.5910.7261.9317.57
P/E GrowthN/AN/A$0.89N/AN/A
Net Margins3.82%7.84%44.83%41.69%N/A
Return on Equity (ROE)8.28%11.35%21.96%19.19%N/A
Return on Assets (ROA)3.65%5.57%14.70%17.91%N/A
Annual Payout$0.21$0.58N/AN/AN/A
Dividend Yield0.33%3.26%N/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout Ratio12.21%N/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity Ratio0.32%0.48%0.21%0.01%0.14%
Current Ratio1.33%1.42%4.35%19.04%1.38%
Quick Ratio0.82%1.12%3.82%19.04%1.05%
Ownership Information
Institutional Ownership Percentage0.16%0.19%88.97%4.36%N/A
Insider Ownership PercentageN/AN/A4.03%N/AN/A
Shares Outstanding399.39 million1.56 billion220.83 million652.80 million194.51 million
Next Earnings Date8/13/2020 (Estimated)N/A7/22/2020 (Estimated)8/12/2020 (Estimated)7/27/2020 (Confirmed)
OptionableNot OptionableNot OptionableOptionableNot OptionableNot Optionable

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.